-
-
-
Jakarta, Indonesia
Jeremiah Hilkiah Wijaya, MD
How molecular genotyping and polygenic risk scores are dismantling the Type 1 versus Type 2 binary and ushering in a new era of personalized diabetes care
Srigita Varsha, MD
Teddy Tjahyanto, M.D., M.M., C.PML., AIFO-K.
dr. Sony A. Fatchurrahman